Atrial fibrillation predicts good functional outcome following intravenous tissue plasminogen activator in patients with severe stroke. 2013

Sheng-Feng Sung, and Yu-Wei Chen, and Mei-Chiun Tseng, and Cheung-Ter Ong, and Huey-Juan Lin
Division of Neurology, Department of Internal Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi City, Taiwan.

OBJECTIVE Atrial fibrillation (AF) is associated with poor outcome after intravenous thrombolysis probably due to greater pretreatment stroke severity. We conducted this retrospective study to determine whether AF is an independent predictor for clinical outcome in patients stratified by initial stroke severity. METHODS A total of 143 acute ischemic stroke patients who received intravenous thrombolysis within 3h after onset were enrolled. The patients were categorized according to the baseline stroke severity by National Institute of Health Stroke Scale (NIHSS) score (≤10 vs. >10) and the presence of AF or not. Favorable 90-day outcome was defined as a modified Rankin Scale (mRS) score<2. RESULTS Among the 100 patients with severe stroke (NIHSS>10), those with AF (n=52) had a higher proportion of favorable 90-day outcome than those without AF (31% vs. 8%, P=0.005). After adjustment for age, baseline glucose level, and onset to treatment time, the difference remained significant (odds ratio 5.80, 95% confidence interval 1.63-20.68). In patients with mild stroke (NIHSS≤10), no difference in clinical outcome was found between AF (n=20) and non-AF (n=23) groups. CONCLUSIONS Presence of AF was associated with favorable 90-day outcome following intravenous thrombolysis in patients with severe stroke at baseline, while the association did not exist in patients with mild stroke.

UI MeSH Term Description Entries
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010959 Tissue Plasminogen Activator A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. Alteplase,Plasminogen Activator, Tissue-Type,T-Plasminogen Activator,Tissue-Type Plasminogen Activator,Actilyse,Activase,Lysatec rt-PA,TTPA,Tisokinase,Tissue Activator D-44,Lysatec rt PA,Lysatec rtPA,Plasminogen Activator, Tissue,Plasminogen Activator, Tissue Type,T Plasminogen Activator,Tissue Activator D 44,Tissue Type Plasminogen Activator
D012042 Registries The systems and processes involved in the establishment, support, management, and operation of registers, e.g., disease registers. Parish Registers,Population Register,Parish Register,Population Registers,Register, Parish,Register, Population,Registers, Parish,Registers, Population,Registry
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005260 Female Females
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Sheng-Feng Sung, and Yu-Wei Chen, and Mei-Chiun Tseng, and Cheung-Ter Ong, and Huey-Juan Lin
January 2017, Journal of the neurological sciences,
Sheng-Feng Sung, and Yu-Wei Chen, and Mei-Chiun Tseng, and Cheung-Ter Ong, and Huey-Juan Lin
November 2012, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association,
Sheng-Feng Sung, and Yu-Wei Chen, and Mei-Chiun Tseng, and Cheung-Ter Ong, and Huey-Juan Lin
January 2014, European neurology,
Sheng-Feng Sung, and Yu-Wei Chen, and Mei-Chiun Tseng, and Cheung-Ter Ong, and Huey-Juan Lin
September 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
Sheng-Feng Sung, and Yu-Wei Chen, and Mei-Chiun Tseng, and Cheung-Ter Ong, and Huey-Juan Lin
August 2019, Circulation. Cardiovascular quality and outcomes,
Sheng-Feng Sung, and Yu-Wei Chen, and Mei-Chiun Tseng, and Cheung-Ter Ong, and Huey-Juan Lin
August 2000, Archives of physical medicine and rehabilitation,
Sheng-Feng Sung, and Yu-Wei Chen, and Mei-Chiun Tseng, and Cheung-Ter Ong, and Huey-Juan Lin
March 2011, Stroke,
Sheng-Feng Sung, and Yu-Wei Chen, and Mei-Chiun Tseng, and Cheung-Ter Ong, and Huey-Juan Lin
September 2002, Neurology,
Sheng-Feng Sung, and Yu-Wei Chen, and Mei-Chiun Tseng, and Cheung-Ter Ong, and Huey-Juan Lin
January 2017, Surgical neurology international,
Sheng-Feng Sung, and Yu-Wei Chen, and Mei-Chiun Tseng, and Cheung-Ter Ong, and Huey-Juan Lin
September 2008, Stroke,
Copied contents to your clipboard!